Zepp Health Corp. · NYSE:ZEPP
Zepp Health — Q2 2026 Earnings Presentation
12 slides from Zepp Health's earnings presentation, Sep 1, 2026
Slide 1: Zepp Health Earnings Presentation
Zepp Health Earnings Presentation Second Quarter 2026 Investor Relations 1 September 2026
Slide 2: Table of Contents
Table of Contents 01 2Q26 Financial and Operating Results 06 Adjusted Operating Expenses 02 Revenue 07 Net Income/ Earnings Performance 03 2Q26 Gross Margin 08 Liquidity Position 04 1H26 Gross Margin 09 Business Outlook 05 2Q26 Revenue and Gross Margin Trend 2 Empowering Health, Inspiring Joy
Slide 3: 2Q26 Financial and Operating Results
2Q26 Financial and Operating Results Revenue • Meeting guidance range Adjusted Net • Attributable to Zepp ** Income $63.5 -$12.5 Million Million Units Shipped Amazfit-branded 2Q25 0.6 Million 2Q25 0.7 Million 0.6 Million 0.7 Million Currency: USD **Adjusted net income, a non-GAAP financial measure,
Slide 4: Revenue
Revenue US$ million US$ million +17.5% 115 +6.9% 98 64 59 61.4% (67.3%) 115 98 64 59 (32.7%) 60.6% (32.7%) 2Q25 2Q26 1H25 1H26 Amazfit-branded wearable products Amazfit-branded wearable products 7.5% 7.5% 4 Empowering Health, Inspiring Joy
Slide 5: 2Q26 Gross Margin
2Q26 Gross Margin Gross Profit (USD in Millions） Gross margin As % of sales 37.4% 23.7 36.2% 21.5 (67.3%) (32.7%) 2Q25 2Q26 2Q25 2Q26 5 Empowering Health, Inspiring Joy
Slide 6: 1H26 Gross Margin
1H26 Gross Margin Gross Profit (USD in Millions） Gross margin As % of sales 37.5% 36.6% 43.2 35.9 23.7 (67.3%) (32.7%) 1H25 1H26 1H25 1H26 6 Empowering Health, Inspiring Joy
Slide 7: 2Q26 Revenue and Gross margin trend
2Q26 Revenue and Gross margin trend Revenue (USD in Millions) Gross Margin (USD in Millions) & Gross Margin % 100 $85 Between 40 40.4% $76 40.6% US$70-80 40.3% $34 36.8% 36.8% 38.2% 40.0% 36.2% $64 37.4% $59 37.3% 37.7% $60 30 $29 2% $52 30.0% $24 50 $22 $22 $43 $19 $40 $41 100% 100% 4% $39 20 $16 $
Slide 8: Adjusted Operating Expenses
Adjusted Operating Expenses Adjusted operating expenses Adjusted operating expenses as a % of total revenue (USD in Millions） 100% 75 90% 80% 60 23 70% 22 60% 45 50% 19.7% 22.2% 40% 30 35 26 30% 30.1% 26.4% 15 20% 13 10% 10 10.5% 11.5% 0 0% 1H25 1H26 1H25 1H26 G&A S&M R&D G&A S&M R&D 8 Empowering He
Slide 9: Net Income/ Earnings Performance
Net Income/ Earnings Performance Net Income (loss) Attributable to Zepp Adjusted Net Income (loss) Attributable to Zepp (USD in Millions） (USD in Millions） 0.0 0.0 -10.0 -7.7 -11.3 -10.0 -6.2 -20.0 -12.5 -20.0 -30.0 -27.5 -30.0 -24.3 -31.0 -30.5 -40.0 -40.0 2Q25 2Q26 1H25 1H26 2Q25 2Q26 1H25 1H26 2Q
Slide 10: Liquidity Position
Liquidity Position Liquidity Position Cash and Cash Equivalents (USD in Millions） 400.0 Share Repurchase Program • Until 2026/06/30 - US$17.6 million 200.0 145.8 146.7 140.5 134.5 132.3 128.7 127.7 110.7 112.9 106.3 103.8 102.6 103.2 95.3 - 31 30 30 31 31 30 30 31 31 30 30 31 31 30 3. 6. 9. 2. 3. 6.
Slide 11: Business Outlook
Business Outlook 1 2 3 4 5 • International • Expanding Product • New Product • Growing Value- • Strict Cost Control Expansion Categories Releases Added Service Revenue For the third quarter of 2026, the Company currently expects: • Net revenue to be between USD 68 million and USD 73 million, compare
Slide 12: Thank You!
Thank You! © 2022 Zepp Health Corporation. All Rights Reserved.